Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Role of Vibrational Spectroscopy in the Assessment of Vulval Disease

NCT02223975 is registered in ClinicalTrials.gov with Gloucestershire Hospitals NHS Foundation Trust as lead sponsor.

NCT NCT02223975
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02223975 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Role of Vibrational Spectroscopy in the Assessment of Vulval Disease
Lead sponsor
Gloucestershire Hospitals NHS Foundation Trust
Phase
Observational
Overall status
Suspended
Start date
August 31, 2014
Completion date
August 31, 2018
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atypia not otherwise specified/ low grade dysplasia ('vin 1'), epithelial hyperplasia without atypia, high grade dysplasia - differentiated type ('vin 2-3'), high grade dysplasia - usual type ('vin 2-3'), lichen sclerosus, normal vulval skin, pagets disease of the vulva, squamous cell carcinoma